BIO-TADALAFIL

biomed pharma🇨🇦 Health Canada

Approval Id: 2cd768b2b5975f3b
Drug Approval Canada Name: BIO-TADALAFIL
Product Name: BIO-TADALAFIL
Status: Marketed
Status Date: 2021-07-28
Original Market Date: 2021-07-28
Din: 02508729
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:12.12
Atc Original: G04BE08 TADALAFIL
Atc Name: g 04 be 08
Aig Number: 0149485002
Company Name: biomed pharma
Company Address: 1B, 9450 Boul. Langelier, Montreal, Quebec, Canada, H1P 3H8

TADALAFIL

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

2cd768b2b5975f3b

Type

Standard